Explore the Respiratory Preceptorship 2026 at Món Clínic Barcelona, featuring expert sessions on asthma, COPD, pulmonary rehabilitation and respiratory medicine.
Learn why earlier COPD diagnosis and better clinical control during follow-up are essential to reduce exacerbations, improve quality of life and optimise patient outcomes.
Blood biomarkers including CC16, sRAGE and SPD identify pre-COPD lung function trajectories and may improve early COPD risk detection and prevention.
Descubre el Año SEPAR de la Vía Aérea 2026/27 y sigue sus contenidos sobre asma, EPOC y bronquiectasias para mejorar la salud respiratoria.
El estudio P4COPD investiga cómo predecir, prevenir y personalizar el manejo de la pre-EPOC en adultos jóvenes mediante medicina de precisión y biomarcadores.
Jornada RespirAP 2026 con las principales novedades en enfermedades respiratorias, Atención Primaria y Neumología presentadas por expertos nacionales.
The EXACERBANTES Study explores treatable traits in COPD exacerbations, aiming to improve risk assessment and support personalized clinical management.
GOLD and GLI provide a joint position on spirometry for diagnosing COPD, supporting the fixed FEV1/FVC ratio in the appropriate clinical context.
Multi-omic asthma analysis identifies distinct molecular patient groups despite similar clinical characteristics, improving understanding of asthma heterogeneity.
Explore the history of COPD and the evolution of disease concepts, treatment strategies, patient outcomes, pulmonary rehabilitation and clinical management.
